title: [Intermediate-dose cytosine arabinoside in combination with mitoxantrone in the treatment of refractory leukemia].
authors.forename: H
authors.initials: H
authors.lastname: Takeyama
authors.forename: H
authors.initials: H
authors.lastname: Fukutani
authors.forename: T
authors.initials: T
authors.lastname: Takeo
authors.forename: H
authors.initials: H
authors.lastname: Yamada
authors.forename: E
authors.initials: E
authors.lastname: Watanabe
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D012074:Remission Induction
chemical_list: D003561:Cytarabine; D008942:Mitoxantrone